Sanjiv Patel

Chief Executive Officer, Relay Therapeutics

Search every verified Sanjiv Patel interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Sanjiv Patel, chief executive officer of Relay Therapeutics, discussed the company's progress and goals in a January 2020 podcast appearance. He stated that Relay Therapeutics planned to enter the clinic in 2020, with multiple drug programs expected to begin clinical trials that year, describing this as a major milestone for the company. Patel noted that the company had transitioned from a theoretical concept to having practical compounds in the clinic over a three-year period. Patel also described the company's focus on developing medicines for targets that the pharmaceutical industry has traditionally considered "undruggable." He attributed the difficulty of these targets to the failure of conventional small-molecule approaches, while expressing that this does not mean such targets will remain inaccessible permanently. He cited advances in sequencing data as providing information to identify relevant targets for drug discovery.